Biotherapeutics Antibody for the Treatment of Solid Cancers

BioTherapeutics is focused on developing innovative antibody-based cancer treatments, based on a range of proprietary technologies. These target a number of oncology indications, with a particular focus on cancers with limited treatment options. These include a mixture of solid and liquid malignancies, such as acute myeloid leukemia and breast, ovarian and lung cancers. Monoclonal antibodies have emerged as a class of novel oncology therapeutics. 

  • Advances in bispecific biotherapeutics for the treatment of cancer
  • Antibody-drug conjugates for cancer therapy
  • Angiogenesis inhibitor antibodies
  • Biotherapeutic approaches to target cancer stem cells

Related Conference of Biotherapeutics Antibody for the Treatment of Solid Cancers

April 04-05, 2024

38th International Conference on Immunology

Madrid, Spain
May 23-24, 2024

18th International Conference on European Immunology

Zurich, Switzerland

Biotherapeutics Antibody for the Treatment of Solid Cancers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in